Key Takeaways Axon revealed plans for a $1.0 billion offering of convertible senior notes with 0% interest, maturing in 2031 The offering includes a $150 million greenshoe option for underwri
Shares of Axon Enterprise (AXON) tumbled nearly 10% during Tuesday’s trading session following the company’s announcement of a $1.0 billion convertible senior notes offering with zero interest, set to mature in 2031. Trading around $442 at the time of publication, the stock shed more than $47 per share.
These convertible senior notes represent unsecured senior obligations of the company and will not accrue periodic interest payments. The maturity date is scheduled for September 15, 2031, provided they aren’t converted, redeemed, or repurchased earlier.
The company has provided underwriters with a greenshoe option allowing them to acquire an additional $150 million worth of notes should demand warrant it, potentially pushing the total offering size to $1.15 billion.
When conversion occurs, Axon retains the right to settle with noteholders using cash, shares of common stock, or a combination of both methods. While this settlement flexibility is typical for such financial instruments, it introduces uncertainty regarding potential shareholder dilution.
To address dilution concerns, Axon intends to allocate a portion of the offering proceeds toward capped call transactions. This strategic move aims to minimize the dilutive impact on existing shareholders when and if conversion takes place.
The balance of the funds raised will be directed toward general corporate needs, including financing growth initiatives and potentially pursuing acquisitions or investments in complementary product offerings, services, or technological innovations.
In a concurrent move Tuesday, Axon finalized a second amendment to its current credit agreement, increasing its revolving credit facility from $300 million to $500 million. The amendment also permits an additional $150 million accordion feature if needed.
The enhanced facility bears interest calculated at SOFR plus a spread ranging from 1.25% to 1.75%, and pushes the maturity date forward by as much as five years from when the amendment closes. This expansion is contingent upon the successful execution of the convertible notes transaction.
The revised credit agreement introduces both leverage and interest coverage covenant requirements, providing Axon with enhanced financial maneuverability to pursue expansion opportunities and potential strategic acquisitions.
Notwithstanding Tuesday’s sharp decline, Wall Street’s latest analyst rating on AXON remains at Buy, with a $825 price target. This projection suggests substantial appreciation potential from present price levels even accounting for the selloff.
Goldman Sachs, Morgan Stanley, JP Morgan, RBC Capital Markets, and Citigroup serve as joint lead coordinators for the notes transaction.
Beginning September 20, 2029, Axon gains the right to redeem some or all outstanding notes for cash if the company’s stock price reaches or exceeds 130% of the conversion price for a minimum of 20 trading sessions within any consecutive 30-trading-day window.
Prior to Tuesday’s downturn, Axon’s market capitalization hovered around $38.94 billion. The company currently trades at a P/E ratio near 204, indicating a premium growth-oriented valuation that offers minimal margin for unexpected developments.
The convertible notes have been registered pursuant to the Securities Act of 1933 as a public offering, ensuring complete compliance with SEC disclosure mandates.
The post Axon Enterprise (AXON) Stock Plunges 10% After $1B Convertible Note Announcement appeared first on Blockonomi.
